1. Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España: 2023 [Internet]. 2023. Available from: https://seom.org/images/Las_cifras_del_Cancer_en_Espana_2023.pdf.
2. National Cancer Institute: Surveillance Epidemiology and End Results Program. SEER Cancer Statistics Review (CSR) 1975-2014 [Internet]. 2018. Available from: https://seer.cancer.gov/archive/csr/1975_2014/results_merged/sect_04_breast.pdf.
3. European Society for Medical Oncology. HER2 in Breast Cancer: ESMO Biomarker Factsheet [Internet]. 2015. Available from: https://oncologypro.esmo.org/education-library/factsheets-on-biomarkers/her2-in-breast-cancer. Accessed 3 Oct 2023.
4. Cortesi L, Rugo HS, Jackisch C. An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol. 2021;16:255–82.
5. Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347–61.